Royal Bank of Canada’s Ascendis Pharma ASND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$297K Sell
1,723
-30,413
-95% -$5.24M ﹤0.01% 4533
2025
Q1
$5.01M Sell
32,136
-208
-0.6% -$32.4K ﹤0.01% 2020
2024
Q4
$4.45M Buy
32,344
+30,617
+1,773% +$4.22M ﹤0.01% 2112
2024
Q3
$258K Sell
1,727
-5,718
-77% -$854K ﹤0.01% 4185
2024
Q2
$1.02M Buy
7,445
+298
+4% +$40.7K ﹤0.01% 3112
2024
Q1
$1.08M Sell
7,147
-288
-4% -$43.6K ﹤0.01% 3029
2023
Q4
$936K Buy
7,435
+572
+8% +$72K ﹤0.01% 3237
2023
Q3
$642K Sell
6,863
-3,150
-31% -$295K ﹤0.01% 3368
2023
Q2
$894K Buy
10,013
+9,013
+901% +$805K ﹤0.01% 3082
2023
Q1
$107K Sell
1,000
-66
-6% -$7.06K ﹤0.01% 4750
2022
Q4
$131K Sell
1,066
-437
-29% -$53.7K ﹤0.01% 4790
2022
Q3
$155K Sell
1,503
-971
-39% -$100K ﹤0.01% 4493
2022
Q2
$230K Buy
2,474
+85
+4% +$7.9K ﹤0.01% 4258
2022
Q1
$281K Buy
2,389
+732
+44% +$86.1K ﹤0.01% 4315
2021
Q4
$223K Sell
1,657
-509
-23% -$68.5K ﹤0.01% 4713
2021
Q3
$345K Buy
2,166
+310
+17% +$49.4K ﹤0.01% 4176
2021
Q2
$244K Buy
1,856
+69
+4% +$9.07K ﹤0.01% 4439
2021
Q1
$231K Buy
1,787
+227
+15% +$29.3K ﹤0.01% 4357
2020
Q4
$260K Buy
1,560
+277
+22% +$46.2K ﹤0.01% 4145
2020
Q3
$198K Buy
1,283
+59
+5% +$9.11K ﹤0.01% 4093
2020
Q2
$181K Buy
1,224
+324
+36% +$47.9K ﹤0.01% 4069
2020
Q1
$101K Hold
900
﹤0.01% 4281
2019
Q4
$125K Sell
900
-15
-2% -$2.08K ﹤0.01% 4379
2019
Q3
$88K Hold
915
﹤0.01% 4281
2019
Q2
$106K Buy
915
+15
+2% +$1.74K ﹤0.01% 4226
2019
Q1
$106K Sell
900
-100
-10% -$11.8K ﹤0.01% 4146
2018
Q4
$63K Hold
1,000
﹤0.01% 4315
2018
Q3
$71K Buy
1,000
+997
+33,233% +$70.8K ﹤0.01% 4457
2018
Q2
$0 Sell
3
-1
-25% ﹤0.01% 5900
2018
Q1
$0 Sell
4
-15
-79% ﹤0.01% 5694
2017
Q4
$1K Buy
+19
New +$1K ﹤0.01% 5600
2016
Q1
Sell
-6
Closed 5600
2015
Q4
$0 Sell
6
-36
-86% ﹤0.01% 5836
2015
Q3
$1K Sell
42
-141
-77% -$3.36K ﹤0.01% 5852
2015
Q2
$3K Buy
+183
New +$3K ﹤0.01% 5806